top of page
Executive Spotlights

Electra Therapeutics Appoints Kathy Dong as President and CEO

South San Francisco, CA, December 11, 2023 (Business Wire) -- Electra Therapeutics, Inc. has named Kathy Dong, PharmD, MBA, as President and CEO. Dr. Dong steps into this role as Electra sees positive clinical outcomes for its lead drug, ELA026, addressing the life-threatening inflammatory disease, secondary hemophagocytic lymphohistiocytosis (sHLH).

Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma


Life Science Headlines
bottom of page